Dimethoxybromoamphetamine (DOB), also known as brolamfetamine ()
and bromo-DMA, is a
psychedelic drug
Psychedelics are a subclass of hallucinogenic drugs whose primary effect is to trigger non-ordinary mental states (known as psychedelic experiences or "trips") and a perceived "expansion of consciousness". Also referred to as classic halluc ...
and
substituted amphetamine
Substituted amphetamines, or simply amphetamines, are a chemical class, class of compounds based upon the amphetamine structure; it includes all derivative (chemistry), derivative compounds which are formed by replacing, or substitution reacti ...
of the
phenethylamine class of compounds. DOB was first synthesized by
Alexander Shulgin in 1967.
[Erowid Online Books: "PiHKAL" - #62 DOB](_blank)
/ref> Its synthesis and effects are documented in Shulgin's book '' PiHKAL: A Chemical Love Story''.
The drug acts as a serotonin
Serotonin (), also known as 5-hydroxytryptamine (5-HT), is a monoamine neurotransmitter with a wide range of functions in both the central nervous system (CNS) and also peripheral tissues. It is involved in mood, cognition, reward, learning, ...
5-HT2 receptor agonist
An agonist is a chemical that activates a Receptor (biochemistry), receptor to produce a biological response. Receptors are Cell (biology), cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an R ...
.
Side effects
Excessively high doses of DOB may cause diffuse arterial spasm. The vasospasm responded readily to intra-arterial and intravenous vasodilators, such as tolazoline
Tolazoline is a non-selective Competitive antagonist, competitive Alpha blocker#Classification, α-adrenergic receptor antagonist. It is a vasodilator that is used to treat spasms of peripheral blood vessels (as in acrocyanosis). It has also been ...
.
Interactions
Pharmacology
Pharmacodynamics
DOB is a serotonin
Serotonin (), also known as 5-hydroxytryptamine (5-HT), is a monoamine neurotransmitter with a wide range of functions in both the central nervous system (CNS) and also peripheral tissues. It is involved in mood, cognition, reward, learning, ...
5-HT2A, 5-HT2B, and 5-HT2C receptor agonist
An agonist is a chemical that activates a Receptor (biochemistry), receptor to produce a biological response. Receptors are Cell (biology), cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an R ...
. Its psychedelic effects are mediated by its agonist
An agonist is a chemical that activates a Receptor (biochemistry), receptor to produce a biological response. Receptors are Cell (biology), cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an R ...
ic properties at the 5-HT2A receptor. Due to its selectivity, DOB is often used in scientific research when studying the 5-HT2 receptor subfamily.
It is a very weak agonist
An agonist is a chemical that activates a Receptor (biochemistry), receptor to produce a biological response. Receptors are Cell (biology), cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an R ...
of the human trace amine-associated receptor 1 (TAAR1) and a weak agonist of the rhesus monkey
The rhesus macaque (''Macaca mulatta''), colloquially rhesus monkey, is a species of Old World monkey. There are between six and nine recognised subspecies split between two groups, the Chinese-derived and the Indian-derived. Generally brown or g ...
TAAR1. In contrast to the serotonin releasing agent MDMA, DOB does not produce protein kinase C (PKC) activation in the brains of rodents ''in vivo
Studies that are ''in vivo'' (Latin for "within the living"; often not italicized in English) are those in which the effects of various biological entities are tested on whole, living organisms or cells, usually animals, including humans, an ...
''. The PKC activation by MDMA appears to be dependent on uptake by the serotonin transporter (SERT).
DOB has been found to reduce aggression
Aggression is behavior aimed at opposing or attacking something or someone. Though often done with the intent to cause harm, some might channel it into creative and practical outlets. It may occur either reactively or without provocation. In h ...
in rats.
Chemistry
The full name of the chemical is 2,5-dimethoxy-4-bromoamphetamine. DOB has a stereocenter
In stereochemistry, a stereocenter of a molecule is an atom (center), axis or plane that is the focus of stereoisomerism; that is, when having at least three different groups bound to the stereocenter, interchanging any two different groups cr ...
and ''R''-(−)-DOB is the eutomer. This is an important finding as it is suggestive that it is targeting different receptors relative to most other phenethylamines (e.g. MDMA) where the ''R''-isomer serves as the distomer. The toxicity of DOB is not fully known, although high doses may cause serious vasoconstriction of the extremities. DOB is one of the most potent compounds in PiHKAL; while the active dose is similar to that of DOI, another psychedelic amphetamine, DOB has been shown to have a higher efficacy in triggering downstream effects mediated by 5-HT2 receptors, making it likely to be slightly more dangerous than DOI in overdose, due to greater vasoconstrictive action. Omission of the amphetamine related α-methyl leads to 2C-B, a compound that possesses a lower affinity for the 5-HT2A receptor and is a weaker receptor agonist which results in drastically reduced vasoconstriction.
History
DOB was first synthesized by Alexander Shulgin in 1967. It was first described in the scientific literature
Scientific literature encompasses a vast body of academic papers that spans various disciplines within the natural and social sciences. It primarily consists of academic papers that present original empirical research and theoretical ...
in a paper by Shulgin, Claudio Naranjo, and another colleague in 1971. The of DOB, ''brolamfetamine'', was proposed and recommended by the World Health Organization
The World Health Organization (WHO) is a list of specialized agencies of the United Nations, specialized agency of the United Nations which coordinates responses to international public health issues and emergencies. It is headquartered in Gen ...
(WHO) in 1986. This was the same year that the Multidisciplinary Association for Psychedelic Studies (MAPS) was founded. DOB was registered with the WHO as a supposed " anorexic" (appetite suppressant).
Society and culture
Legal status
Internationally, DOB is a Schedule I substance under the Convention on Psychotropic Substances and the drug is legal only for medical, industrial or scientific purposes.
Canada
Listed as a Schedule 1 as it is an analogue of amphetamine.
Australia
DOB is considered a Schedule 9 prohibited substance in Australia under the Poisons Standard (February 2017). A Schedule 9 substance is a substance which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.
Russia
Schedule I, possession of at least 10 mg is a criminal offence.
United Kingdom
DOB is a Class A drug in the United Kingdom under the Misuse of Drugs Act 1971.
United States
DOB is a Schedule I controlled substance under federal law in the United States
The United States of America (USA), also known as the United States (U.S.) or America, is a country primarily located in North America. It is a federal republic of 50 U.S. state, states and a federal capital district, Washington, D.C. The 48 ...
. It was scheduled in 1973.
See also
* 2,5-Dimethoxy-4-substituted amphetamines
* 2C-B – the α-desmethyl derivative of DOB
* 4C-B – the α-ethyl homologue of DOB
* β-Methyl-2C-B
* DOB-FLY
References
External links
DOB - Isomer Design
DOB - PsychonautWiki
DOB - Erowid
DOB - TripSit
The Big & Dandy DOB Thread - Bluelight
DOB - PiHKAL - Erowid
DOB - PiHKAL - Isomer Design
{{DEFAULTSORT:Dimethoxy-4-bromoamphetamine, 2,5-
5-HT2A agonists
5-HT2B agonists
5-HT2C agonists
Bromobenzene derivatives
Designer drugs
DOx (psychedelics)
Serotonin receptor agonists
TAAR1 agonists